Blackstone Life Sciences clinches royalty deal with Medtronic, Apollo-spinout Nexus Capital targets $1bn-plus for next fund, Kinderhook’s Avita sees big opportunity in pharmacy management

Blackstone invests in Medtronic and Nexus Capital targets $1 billion for new fund.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this